- About VIVUS
- Our Products
- Investors + Media
Access our recent and archived press releases. This section also provides a calendar of upcoming events and presentations.Our Newsroom
Our investor relations portal provides access to our financial information, filings, investor presentations and stock information.Investor Tools
We develop high-potential molecules that have compelling safety and promising efficacy data and transform them into proprietary products that enable significant advances in patient care and outcomes.Our Products
VIVUS is dedicated to meeting the needs and improving quality of life of patients with serious medical conditions and life-limiting diseases.
Exocrine pancreatic insufficiency (EPI) is a condition that results from a deficiency in the production and/or secretion of pancreatic enzymes and can lead to chronic diarrhea, significant weight loss and malnutrition. While there is no cure for EPI, PANCREAZE, a pancreatic enzyme replacement therapy, is an effective therapy for managing the disease.Learn More About EPI Learn More About PANCREAZE